Intranasal treatment of salvinorin A, a highly selective non-opioid kappa opioid receptor agonist, reduced neuroinflammation and BBB permeability in transient MCAO mice (Misilimu et al., 2022)
CEO Lars Fruergaard Jrgensen on Thursday acknowledged the sharp share price reaction after two consecutive late-stage trials showed underwhelming weight reduction versus the company's own targets, but said he nevertheless remained "encouraged" by the drug's weight loss profile
Only in extreme, high-dose medical or cosmetic applications is there any potential for pigment lightening
Nearly half of the respondents report intentionally increasing their consumption of fiber (both soluble and insoluble fibers) since starting GLP-1 treatment, said Brad Schwan, vice president of marketing for ADM
All trademarks, brand names, and product names referenced in this article are the property of their respective owners
Tendon Healing: Tendon injuries are very common, their healing is often difficult, and very slow